Journal for ImmunoTherapy of Cancer (Nov 2021)
587 Inducing mismatch repair deficiency in combination with anti-CTLA4 therapy is highly effective against non-immunogenic neuroblastoma tumors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)